3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Small Cell Lung Carcinoma
8
Lung Neoplasms
4
Sarcoma, Ewing
2
Sarcoma
2
SCLC, Extensive Stage
1
Recurrence
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Gastrointestinal Malignancies
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Vincristine
4
Etoposide
4
Doxorubicin
4
Cyclophosphamide
4
Thiotepa
3
Temozolomide
3
Ifosfamide
3
Filgrastim
3
Cisplatin
3
fludarabine phosphate
2
Radiotherapy
2
Melphalan
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Cytoreduction Surgical Procedures
2
Brachytherapy
2
thymoglobulin
1
temsirolimus
1
sodium thiosulfate
1
prexasertib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
pazopanib
1
pasireotide
1
fludarabine
1
Zoledronic Acid
1
X-Rays
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Desmoplastic Small Round Cell Tumor
×
PM 01183
×
Clear all
NCT05918640
2026-03-31
LiFFT
Children's Hospital of Philadelphia
Phase 1/2
Recruiting
63 enrolled